Inspiration Capital Partners Completes its Acquisition of Antute
Inspiration Capital Partners (“ICP”) today announced that it has completed its acquisition of Antute (Beijing) Technology Limited (“Antute”), a leading… Read More »
ImmVira’s breakthrough intravenous oncolytic virus product MVR-T3011 IV completed first dosing in Phase I clinical trial in China
Following its robust safety data in the U.S. Phase I clinical study, ImmVira announced that its global first intravenous administered… Read More »
ZTE Applauded by Frost & Sullivan for Enabling Sustainable Development through Carbon Neutrality and Addressing 5G-related Needs With Its Path-breaking Telecom Power Solutions
ZTE’s Telecom Power solutions leverage Big Data and artificial intelligence (AI) to improve and optimize energy efficiency and operations and… Read More »
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today the Investigational New Drug (IND) approval of its Bruton’s tyrosine… Read More »
The Second Home (Sky Link) Plan Released, Asian Iron Man Streaks into Space
Civil space infrastructure has been increasingly improving, while commercial aerospace market is developing rapidly with each passing day. By dint… Read More »
Mascots of China int’l consumer products expo revealed
Authorities in South China’s Hainan Province on Tuesday revealed the mascots for the 2022 China International Consumer Products Expo, styled… Read More »
REDCLOUD BIO ANNOUNCES FDA ACCEPTANCE OF IND APPLICATION FOR NEXT-GENERATION EGFR INHIBITOR H002 IN NON-SMALL CELL LUNG CANCER
Drug Candidate Is First From Company To Enter Phase I/IIa Clinical Trial H002 Has Potential To Overcome Resistance Driven By… Read More »
Extensive Global Cross-Media Journalism Campaign “Ningbo, Setting Sail to Embrace the World” Launched in Ningbo, China
On the morning of March 2, 2022 (Beijing time), “Ningbo, Setting Sail to Embrace the World”, a large-scale cross-media journalism… Read More »
Adagene Announces SAFEbody® Multi-Target Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody Candidates
Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, today announced a collaboration and… Read More »
Sonata Software Named Microsoft Azure Expert Managed Service Provider
Sonata Software, a global IT Services and Technology Solutions Company, today announced that it has been named a Microsoft Azure… Read More »